Ulrich Baumann

机构：Medizinische Hochschule Hannover · ORCID：0000-0002-0162-0266

发表论文 329 篇 · 总被引 10372 次 · h-index 53

代表论文

• Gene Therapy in Patients with the Crigler–Najjar Syndrome (2023 · New England Journal of Medicine · 被引 83)
• Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity (2023 · Journal of Allergy and Clinical Immunology · 被引 76)
• Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial (2024 · ˜The œLancet. Gastroenterology & hepatology · 被引 70)
• Prospective Newborn Screening for SCID in Germany: A First Analysis by the Pediatric Immunology Working Group (API) (2023 · Journal of Clinical Immunology · 被引 55)
• Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial (2024 · ˜The œLancet. Gastroenterology & hepatology · 被引 54)
• Current genetic diagnostics in inborn errors of immunity (2024 · Frontiers in Pediatrics · 被引 44)